Primitive hematopoietic cells resist HIV-1 infection via p21 Waf1/Cip1/Sdi1

Journal of Clinical Investigation

Volumn 117, Issue 2, 2007, Pages 473-481

  Zhang, Jielin ^a   Scadden, David T ^a,b,c   Crumpacker, Clyde S ^a,d  

^a HARVARD MEDICAL SCHOOL   (United States)

^b HARVARD STEM CELL INSTITUTE   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CYCLIN DEPENDENT KINASE INHIBITOR 1; INTEGRASE; PROMYELOCYTIC LEUKEMIA PROTEIN; TRIPARTITE MOTIF PROTEIN 5;

ARTICLE; CONTROLLED STUDY; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION;

BASE SEQUENCE; CARRIER PROTEINS; CELL CYCLE; CELLS, CULTURED; CYCLIN-DEPENDENT KINASE INHIBITOR P21; HEMATOPOIETIC STEM CELLS; HIV INFECTIONS; HIV-1; HUMANS; INTERFERON-ALPHA; NEOPLASM PROTEINS; NUCLEAR PROTEINS; PROTEINS; RNA INTERFERENCE; RNA, MESSENGER; RNA, SMALL INTERFERING; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEINS; VIRUS INTEGRATION; VIRUS REPLICATION;

EID: 33846809447     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI28971     Document Type: Article

References (53)

1. Shen, H., et al. 1999. Intrinsic human immunodeficiency virus type 1 resistance of hematopoietic stem cells despite coreceptor expression. J. Virol. 73:728-737.
2. Weichold, F.F., et al. 1998. Neither human immunodeficiency virus-1 (HIV-1) nor HIV-2 infects most-primitive human hematopoietic stem cells as assessed in long-term bone marrow cultures. Blood. 91:907-915.
3. Von Laer, D., et al. 1990. CD34+ hematopoietic progenitor cells are not a major reservoir of the human immunodeficiency virus. Blood. 76:1281-1286.
4. Lee, B., Ratajczak, J., Doms, R.W., Gewirtz, A.M., and Ratajczak, M.Z. 1999. Coreceptor/chemokine receptor expression on human hematopoietic cells: biological implications for human immunodeficiency virus-type 1 infection. Blood. 93:1145-1156.
5. Louache, F., Debili, N., Marandin, A., Coulombel, L., and Vainchenker, W. 1994. Expression of CD4 by human hematopoietic progenitors. Blood. 84:3344-3355.
6. Aiuti, A., et al. 1999. Human CD34(+) cells express CXCR4 and its ligand stromal cell-derived factor-1. Implications for infection by T-cell tropic human immunodeficiency virus. Blood. 94:62-73.
7. Cheng, T., et al. 2000. Hematopoietic stem cell quiescence maintained by p21cip1/waf1. Science. 287:1804-1808.
8. Yuan, Y., Shen, H., Franklin, D.S., Scadden, D.T., and Cheng, T. 2004. In vivo self-renewing divisions of haematopoietic stem cells are increased in the absence of the early G1-phase inhibitor, p18INK4C. Nat. Cell Biol. 6:436-442.
9. Steinman, R.A. 2002. Cell cycle regulators and hematopoiesis. Oncogene. 21:3403-3413.
10. Stier, S., et al. 2003. Ex vivo targeting of p21Cip1/Waf1 permits relative expansion of human hematopoietic stem cells. Blood. 102:1260-1266.
11. Cheng, T., Shen, H., Rodrigues, N., Stier, S., and Scadden, D.T. 2001. Transforming growth factor beta 1 mediates cell-cycle arrest of primitive hematopoietic cells independent of p21(Cip1/Waf1) or p27(Kip1). Blood. 98:3643-3649.
12. Stremlau, M., et al. 2004. The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys. Nature. 427:848-853.
13. Marcello, A., et al. 2003. Recruitment of human cyclin T1 to nuclear bodies through direct interaction with the PML protein. EMBO J. 22:2156-2166.
14. Ganesh, L., et al. 2003. The gene product Murr1 restricts HIV-1 replication in resting CD4+ lymphocytes. Nature. 426:853-857.
15. Zhang, J.L., Attar, E.C., Cohen, K.S., Crumpacker, C.S., and Scadden, D.T. 2005. Silencing p21Waf1/Cip1/Sdi1 expression increases gene transduction efficiency in primitive human hematopoietic cells. Gene Ther. 12:1444-1452.
16. Matsumura, I., et al. 1997. Thrombopoietin-induced differentiation of a human megakaryoblastic leukemia cell line, CMK, involves transcriptional activation of p21(WAF1/Cip1) by STAT5. Mol. Cell. Biol. 17:2933-2943.
17. Vainchenker, W., Debili, N., Mouthon, M.A., and Wendling, F. 1995. Megakaryocytopoiesis: cellular aspects and regulation. Crit. Rev. Oncol. Hematol. 20:165-192.
18. Brown, J.P., Wei, W., and Sedivy, J.M. 1997. Bypass of senescence after disruption of p21CIP1/WAF1 gene in normal diploid human fibroblasts. Science. 277:831-834.
19. Coffin, J.M., Hughes, S.H., and Varmus, H.E. 1997. Retroviruses. Cold Spring Harbor Press. Cold Spring Harbor, New York, USA. 843 pp.
20. Engelman, A. 1999. In vivo analysis of retroviral integrase structure and function. Adv. Virus Res. 52:411-426.
21. Hazuda, D.J., et al. 2000. Inhibitors of strand transfer that prevent integration and inhibit HIV-1 replication in cells. Science. 287:646-650.
22. Bukrinsky, M.I., et al. 1993. A nuclear localization signal within HIV-I matrix protein that governs infection of nondividing cells. Nature. 365:666-669.
23. Von Schwedler, U., Kombluth, R.S., and Trono, D. 1994. The nuclear localization signal of the matrix protein of human immunodeficiency virus type 1 allows the establishment of infection in macrophages and quiescent T lymphocytes. Proc. Natl. Acad. Sci. U. S. A. 91:6992-6996.
24. Li, G., Simm, M., Potash, M.J., and Volsky, D.J. 1993. Human immunodeficiency virus type 1 DNA synthesis, integration, and efficient viral replication in growth-arrested T cells. J. Virol. 67:3969-3977.
25. Zhou, Y., Zhang, H., Siliciano, J.D., and Siliciano, R.F. 2005. Kinetics of human immunodeficiency virus type 1 decay following entry into resting CD4+ T cells. J. Virol. 79:2199-2210.
26. Zack, J.A. 1995. The role of the cell cycle in HIV-1 infection. Adv. Exp. Med. Biol. 374:27-31.
27. Clark, E., et al. 2000. Loss of G(1)/S checkpoint in human immunodeficiency virus type 1-infected cells is associated with a lack of cyclin-dependent kinase inhibitor p21/Waf1. J. Virol. 74:5040-5052.
28. Wang, D., et al. 2001. Inhibition of human immunodeficiency virus type 1 transcription by chemical cyclin-dependent kinase inhibitors. J. Virol. 75:7266-7279.
29. Schmitz, J.E., et al. 2005. Effect of CD8+ lymphocyte depletion on virus containment after simian immunodeficiency virus SIVmac251 challenge of live attenuated SIVmac239Delta3-vaccinated rhesus macaques. J. Virol. 79:8131-8141.
30. Yokoyama, S. 1988. Molecular evolution of the human and simian immunodeficiency viruses. Mol. Biol. Evol. 5:645-659.
31. Padow, M., et al. 2003. Replication of chimeric human immunodeficiency virus type 1 (HIV-1) containing HIV-2 integrase (IN): naturally selected mutations in IN augment DNA synthesis. J. Virol. 77:11050-11059.
32. Lau, A., Kanaar, R., Jackson, S.P., and O'Connor, M.J. 2004. Suppression of retroviral infection by the RAD52 DNA repair protein. EMBO J. 23:3421-3429.
33. Daniel, R., et al. 2004. Evidence that stable retroviral transduction and cell survival following DNA integration depend on components of the nonhomologous end joining repair pathway. J. Virol. 78:8573-8581.
34. Li, R., Waga, S., Hannon, G.J., Beach, D., and Stillman, B. 1994. Differential effects by the p21 CDK inhibitor on PCNA-dependent DNA replication and repair. Nature. 371:534-537.
35. Waga, S., Hannon, G.J., Beach, D., and Stillman, B. 1994. The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature. 369:574-578.
36. Chuang, L.S., et al. 1997. Human DNA-(cytosine-5) methyltransferase-PCNA complex as a target for p21WAF1. Science. 277:1996-2000.
37. Qiu, J., et al. 2004. Regenerative response in ischemic brain restricted by p21cip1/waf1. J. Exp. Med. 199:937-945.
38. LaBaer, J., et al. 1997. New functional activities for the p21 family of CDK inhibitors. Genes Dev. 11:847-862.
39. Noseda, M., et al. 2004. Notch activation induces endothelial cell cycle arrest and participates in contact inhibition: role of p21Cip1 repression. Mol. Cell. Biol. 24:8813-8822
40. Stadheim, T.A., Suh, N., Ganju, N., Sporn, M.B., and Eastman, A. 2002. The novel triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid (CDDO) potently enhances apoptosis induced by tumor necrosis factor in human leukemia cells. J. Biol. Chem. 277:16448-16455.
41. Liby, K., et al. 2005. The synthetic triterpenoids, CDDO and CDDO-imidazolide, are potent inducers of heme oxygenase-1 and Nrf2/ARE signaling. Cancer Res. 65:4789-4798.
42. Vazquez, N., et al. 2005. Human immunodeficiency virus type 1-induced macrophage gene expression includes the p21 gene, a target for viral regulation. J. Virol. 79:4479-4491.
43. Roninson, I.B. 2002. Oncogenic functions of tumour suppressor p21(Waf1/Cip1/ Sdi1): association with cell senescence and tumour-promoting activities of stromal fibroblasts. Cancer Lett. 179:1-14.
44. Harper, J.W., et al. 1995. Inhibition of cyclin-dependent kinases by p21. Mol. Biol. Cell. 6:387-400.
45. ACTG Virology Committee. 1994. ACTG Virology Manual for HIV laboratories. 3rd edition. F.B. Hollinger, editor. National Institute of Allergy and Infectious Diseases, NIH. Bethesda, Maryland, USA. http://aactg.s-3.com/labmanual.htm.
46. Lu, R., Ghory, H.Z., and Engelman, E. 2005. Genetic analyses of conserved residues in the carboxyl-terminal domain of human immunodeficiency virus type 1 integrase. J. Virol. 79:10356-10368.
47. Butler, S.L., Hansen, M.S., and Bushman, F.D. 2001. A quantitative assay for HIV DNA integration in vivo. Nat. Med. 7:631-634.
48. Zhang, J.L., and Crumpacker, C.S. 2002. Human immunodeficiency virus type 1 nucleocapsid protein nuclear localization mediates early viral mRNA expression. J. Virol. 76:10444-10454.
49. O'Doherty, U., Swiggard, W.J., Jeyakumar, D., McGain, D., and Malim, M.H. 2002. A sensitive, quantitative assay for human immunodeficiency virus type 1 integration. J. Virol. 76:10942-10950.
50. Lin, C.W., and Engelman, A. 2003. The barrier-to-autointegration factor is a component of functional human immunodeficiency virus type 1 preintegration complexes. J. Virol. 77:5030-5036.
51. Niedrig, N., et al. 1989. Epitope mapping of monoclonal antibodies against human immunodeficiency virus type 1 structural proteins using peptides. J. Virol. 63:3525-3528.
52. Nilsen, B.M., et al. 1996. Monoclonal antibodies against human immunodeficiency virus type 1 integrase: epitope mapping and differential effects on integrase activities in vitro. J. Virol. 70:1580-1587.
53. Zandstra, P.W., Lauffenburger, D.A., and Eaves, C.J. 2000. A ligand-receptor signaling threshold model of stem cell differentiation control: a biologically conserved mechanism applicable to hematopoiesis. Blood. 96:1215-1222.